Organization (Industry)
HILL-ROM HOLDINGS, INC.
ClinicalTrials.gov lists HILL-ROM HOLDINGS, INC. as lead sponsor of 25 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo The original uploader was Random Task at English Wikipedia ., via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers HILL-ROM HOLDINGS, INC.: 25 lead-sponsored trials and 1 legal-entity registration. Part of BAXTER INTERNATIONAL INC.
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Disease areas (21)
Shown in this order: most trials first (counted at this company's own legal-entity record, not the consolidated group).
| Disease area | Trials |
|---|---|
| Pressure Ulcer | 8 |
| Cystic Fibrosis | 5 |
| Pulmonary Atelectasis | 2 |
| Asthma | 2 |
| Bronchiectasis | 2 |
Showing 5 of 21 disease areas.
Trials by start year as sponsor or collaborator (14)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2020 | 3 |
| 2019 | 3 |
| 2018 | 2 |
| 2017 | 4 |
| 2016 | 2 |
| 2015 | 1 |
| 2014 | 1 |
| 2011 | 2 |
| 2010 | 4 |
| 2008 | 5 |
Showing 10 of 14 years.
Recruitment duration, a model prediction: none of the 25 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 0 of 3 hit target (n=3) | 0 of 3 on time (n=3) |
FDA inspection record (1)
| Latest classification | Inspections |
|---|---|
| NAI | 14 |
FDA recalls (37)
Shown in this order: most recent first.
| Product | Classification | Initiated |
|---|---|---|
| (1)Traverse Rail Carrier E-System, wide 31017XX component to Liko overhead lift, (2)Traverse Rail Carrier 31025XX component to Liko overhead lift. Intended for to make safe lifting of a patient possible. Affected Devices: 3101704 TRAV RAIL CARR E-SYST STD 3102514 TR CARRIER SLIM/RAISED, LR 3101705 TRAV RAIL CARR ESYST WIDE 3102517 TR CARR. NORMAL/LOWER. LR 3102506 TR CARRIER WIDE/RAISED ML 3102519 TR CARR. LOW.LR 30MM/PAIR 3102511 TR CARRIER NORMAL, LR 3102531 TRAVERSE RL CARRIER STD/RAISED 3102512 TR CARRIER WIDE, LR 3102532 TRAVERSE RL CARRIER WD/RAISED 3102513 TR CARRIER SLIM, LR 3102562 TR CARRIER, PARALLEL/WIDE | Class II | 2022-01-14 |
| Liko Mobile Lifts: Primarily intended for use in nursing homes Liko M220, Model 2050010 | Class II | 2021-12-23 |
| Liko Mobile Lifts: Primarily intended for use in nursing homes LikoM230 Model: 2050015 | Class II | 2021-12-23 |
| These are communication systems, labeled as: a. NaviCare Nurse Call, Part Numbers: 3.6, 3.7, 3.9 b. Voalte Nurse Call, Part Number 4.0 *Product was rebranded from NaviCare to Voalte in 2020 | Class II | 2021-10-14 |
| OctoStretch with Stretch Leveller - The combination of this products allows the user to easily adjust/control the center of gravity during lift of patient. Model Number: 3156056 | Class II | 2021-08-11 |
Showing 5 of 37 recalls.
FDA import refusals (1)
| Refused import lines | Latest refusal |
|---|---|
| 1 | 2020-05-16 |
Manufacturing and distribution sites (3)
Shown in this order: severity rank then name.
| Facility | Location | Regulators | Member organization |
|---|---|---|---|
| HILL-ROM, INC. | Raleigh, US | FDA | |
| HILL-ROM, INC. | Batesville, US | FDA | |
| Hill-Rom Company, Inc. | Ladson, US | FDA |
Biomarker capability evidence (9)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| APOC1 | Trial collaborator | Named in trial inclusion criteria |
| APOC2 | Trial collaborator | Named in trial inclusion criteria |
| NTM | Trial sponsor | Named in trial exclusion criteria |
| APOC1 | Trial collaborator | Mentioned in trial text |
| APOC2 | Trial collaborator | Mentioned in trial text |
Showing 5 of 9 evidence rows.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, climate targets, as filed, workforce and board diversity, as filed, organization relationships, and clia clinical laboratory certificates.
Counted at group level under Baxter International Inc: journals published in, us granted patents, latest dated events, and biomarkers this organization publishes on.